Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
about
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesPhase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines.Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
P2860
Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modulation of chemokines in th ...... otherapy for colorectal cancer
@en
Modulation of chemokines in th ...... therapy for colorectal cancer.
@nl
type
label
Modulation of chemokines in th ...... otherapy for colorectal cancer
@en
Modulation of chemokines in th ...... therapy for colorectal cancer.
@nl
prefLabel
Modulation of chemokines in th ...... otherapy for colorectal cancer
@en
Modulation of chemokines in th ...... therapy for colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Modulation of chemokines in th ...... otherapy for colorectal cancer
@en
P2093
David L Bartlett
Deepa Magge
Julie A Urban
Lily Francis
Magesh Sathaiah
Pawel Kalinski
Roshni Ravindranathan
Zong Sheng Guo
Zuqiang Liu
P2860
P304
22174-22185
P356
10.18632/ONCOTARGET.7907
P407
P577
2016-03-04T00:00:00Z